|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$552,983
|
$110,596
|
Hickstein, Dennis
|
CCR (NCI)
|
|
Zebrafish Chemical and Classical Genetics Approach to the Pathogenesis of T-ALL
|
5K08CA133103-04
|
$140,940
|
$140,940
|
Gutierrez, Alejandro
|
DANA-FARBER CANCER INSTITUTE
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S1
|
$35,000
|
$2,100
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S2
|
$5,000
|
$300
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-33
|
$1,795,225
|
$107,714
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
XV International Conference on Human Retrovirology: HTLV and Related Viruses
|
1R13CA159758-01
|
$2,000
|
$2,000
|
MURPHY, EDWARD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-14
|
$330,937
|
$43,022
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Washington University Molecular Imaging Center
|
5P50CA094056-11
|
$1,765,050
|
$388,311
|
PIWNICA-WORMS, David
|
WASHINGTON UNIVERSITY
|
|
Vitamin D Analogs as Adjuvants in Chemotherapy
|
5R01CA044722-21
|
$199,759
|
$199,759
|
Studzinski, GEORGE
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010126-00580
|
$48,591
|
$4,859
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-21S1
|
$50,000
|
$1,000
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
5U10CA052784-21
|
$490,679
|
$9,814
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Validation of microRNAs as therapeutic targets in hematological malignancies
|
1R01CA135332-01A2
|
$316,438
|
$316,438
|
MARCUCCI, GUIDO
|
OHIO STATE UNIVERSITY
|
|
Validating Syk as a Target for AML Therapy
|
5R01CA140292-03
|
$352,231
|
$352,231
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INSTITUTE
|
|
Validating a novel biomarker of clinical progression and survival in CLL
|
1R33CA161731-01
|
$364,620
|
$364,620
|
DAVIS, RANDALL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S1
|
$74,970
|
$2,249
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S2
|
$139,926
|
$4,198
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-38
|
$4,555,705
|
$136,671
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UT M.D. Anderson Cancer Center Lymphoma SPORE
|
5P50CA136411-03
|
$475,000
|
$109,250
|
YOUNES, ANAS
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-23
|
$2,179,856
|
$348,777
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
2P30CA014089-36
|
$6,160,984
|
$616,098
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S1
|
$50,000
|
$5,000
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S2
|
$244,500
|
$24,450
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S3
|
$74,923
|
$7,492
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
3U54CA096297-09S1
|
$201,528
|
$40,306
|
Frontera, Walter
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
5U54CA096297-09
|
$1,494,018
|
$298,804
|
Frontera, Walter
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
5U54CA096300-09
|
$1,210,404
|
$242,081
|
DUBOIS, RAYMOND
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UNMC Eppley Cancer Center Support Grant
|
2P30CA036727-25
|
$1,504,111
|
$45,123
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-25S1
|
$74,642
|
$2,239
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
|
5P50CA100632-09
|
$2,185,000
|
$2,185,000
|
Kantarjian, Hagop
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Rochester Cancer Center CCOP Research Base
|
5U10CA037420-27
|
$2,137,632
|
$21,376
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-07S1
|
$49,474
|
$6,432
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-07S2
|
$75,000
|
$9,750
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-07S3
|
$140,000
|
$18,200
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-07
|
$1,934,104
|
$251,434
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S2
|
$50,000
|
$3,000
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S3
|
$5,694,947
|
$341,697
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Colorado Southwest Oncology Group
|
5U10CA042777-24
|
|
$0
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$218,895
|
$87,558
|
Fowler, Daniel
|
CCR (NCI)
|
|
Understanding Hemotopoietic Neoplasias using Humanized Mice
|
5R01CA156689-02
|
$507,346
|
$253,673
|
FLAVELL, RICHARD
|
YALE UNIVERSITY
|
|
Uncoupling of Jak/STAT in HTLV-1 associated leukemia
|
5R01CA115398-05
|
$216,737
|
$108,369
|
NICOT, CHRISTOPHE
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
UMass Boston-DF/HCC U54 Partnership (2 of 2)
|
3U54CA156734-02S1
|
$129,367
|
$64,684
|
Colon-Carmona, Adan
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
UMass Boston-DF/HCC U54 Partnership (2 of 2)
|
5U54CA156734-02
|
$1,286,176
|
$643,088
|
Colon-Carmona, Adan
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
UCB-DERIVED CD19-SPECIFIC T CELLS FOR UNIVERSAL TREATMENT OF B-CELL MALIGNANCY
|
5R33CA116127-04
|
$459,850
|
$229,925
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
U10 Full Member Application Affiliated with SWOG
|
5U10CA105409-08
|
$325,684
|
$3,257
|
Kim, Edward
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Tyrosine Kinase Signaling in Cancer Cell Metabolism
|
5R01CA140515-02
|
$315,053
|
$315,053
|
Chen, Jing
|
EMORY UNIVERSITY
|
|
Tyrosine Kinase Regulation Via Protein Degradation
|
2R01CA087986-13A1
|
$269,290
|
$269,290
|
Band, Hamid
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
5R01CA138744-02
|
$338,142
|
$338,142
|
BAKER, SHARYN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Tunable DNA-nanostructure to induce NK-mediated killing of tumor cells
|
5R21CA141021-02
|
$154,564
|
$77,282
|
CHANG, YUNG
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$195,669
|
$19,566
|
Kaplan, Rosandra
|
CCR (NCI)
|
Total relevant funding to Leukemia for this search: $227,025,963
|